163 related articles for article (PubMed ID: 19066434)
1. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice.
Ozmen L; Albientz A; Czech C; Jacobsen H
Neurodegener Dis; 2009; 6(1-2):29-36. PubMed ID: 19066434
[TBL] [Abstract][Full Text] [Related]
2. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
[TBL] [Abstract][Full Text] [Related]
3. Formation of beta-amyloid protein deposits in brains of transgenic mice.
Quon D; Wang Y; Catalano R; Scardina JM; Murakami K; Cordell B
Nature; 1991 Jul; 352(6332):239-41. PubMed ID: 1906990
[TBL] [Abstract][Full Text] [Related]
4. Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load.
Santiard-Baron D; Langui D; Delehedde M; Delatour B; Schombert B; Touchet N; Tremp G; Paul MF; Blanchard V; Sergeant N; Delacourte A; Duyckaerts C; Pradier L; Mercken L
J Neurochem; 2005 Apr; 93(2):330-8. PubMed ID: 15816856
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
[TBL] [Abstract][Full Text] [Related]
6. Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.
Kumar-Singh S; Dewachter I; Moechars D; Lübke U; De Jonghe C; Ceuterick C; Checler F; Naidu A; Cordell B; Cras P; Van Broeckhoven C; Van Leuven F
Neurobiol Dis; 2000 Feb; 7(1):9-22. PubMed ID: 10671319
[TBL] [Abstract][Full Text] [Related]
7. Reduced brain volumes in mice expressing APP-Austrian mutation but not in mice expressing APP-Swedish-Austrian mutations.
Van Broeck B; Vanhoutte G; Cuijt I; Pereson S; Joris G; Timmermans JP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurosci Lett; 2008 Dec; 447(2-3):143-7. PubMed ID: 18840503
[TBL] [Abstract][Full Text] [Related]
8. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.
Bales KR; Verina T; Dodel RC; Du Y; Altstiel L; Bender M; Hyslop P; Johnstone EM; Little SP; Cummins DJ; Piccardo P; Ghetti B; Paul SM
Nat Genet; 1997 Nov; 17(3):263-4. PubMed ID: 9354781
[No Abstract] [Full Text] [Related]
9. Age-related impairments in operant DMTP performance in the PS2APP mouse, a transgenic mouse model of Alzheimer's disease.
Woolley ML; Ballard TM
Behav Brain Res; 2005 Jun; 161(2):220-8. PubMed ID: 15922048
[TBL] [Abstract][Full Text] [Related]
10. Deprivation-induced dendritic shrinkage might be oppositely affected by the expression of wild-type and mutated human amyloid precursor protein.
Alpár A; Naumann N; Ueberham U; Arendt T; Gärtner U
J Neurosci Res; 2009 Jun; 87(8):1813-22. PubMed ID: 19170186
[TBL] [Abstract][Full Text] [Related]
11. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
[TBL] [Abstract][Full Text] [Related]
12. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
[TBL] [Abstract][Full Text] [Related]
13. Deficient cerebral clearance of vasculotropic mutant Dutch/Iowa Double A beta in human A betaPP transgenic mice.
Davis J; Xu F; Miao J; Previti ML; Romanov G; Ziegler K; Van Nostrand WE
Neurobiol Aging; 2006 Jul; 27(7):946-54. PubMed ID: 16105708
[TBL] [Abstract][Full Text] [Related]
14. APP mRNA splicing is upregulated in the brain of biglycan transgenic mice.
Bjelik A; Pákáski M; Bereczki E; Gonda S; Juhász A; Rimanóczy A; Zana M; Janka Z; Sántha M; Kálmán J
Neurochem Int; 2007 Jan; 50(1):1-4. PubMed ID: 16962684
[TBL] [Abstract][Full Text] [Related]
15. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency.
Stoltenberg M; Bush AI; Bach G; Smidt K; Larsen A; Rungby J; Lund S; Doering P; Danscher G
Neuroscience; 2007 Dec; 150(2):357-69. PubMed ID: 17949919
[TBL] [Abstract][Full Text] [Related]
16. [Dominant forms of Alzheimer's disease: from genotype to phenotype].
Hannequin D; Campion D
Rev Neurol (Paris); 2001 Apr; 157(4):384-92. PubMed ID: 11398010
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides determine the amyloid pathology of Alzheimer's disease.
Oikawa N; Yamaguchi H; Ogino K; Taki T; Yuyama K; Yamamoto N; Shin RW; Furukawa K; Yanagisawa K
Neuroreport; 2009 Aug; 20(12):1043-6. PubMed ID: 19590389
[TBL] [Abstract][Full Text] [Related]
18. Genetic and pharmacological evidence of intraneuronal Abeta accumulation in APP transgenic mice.
Philipson O; Lannfelt L; Nilsson LN
FEBS Lett; 2009 Sep; 583(18):3021-6. PubMed ID: 19683527
[TBL] [Abstract][Full Text] [Related]
19. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice.
Minkeviciene R; Ihalainen J; Malm T; Matilainen O; Keksa-Goldsteine V; Goldsteins G; Iivonen H; Leguit N; Glennon J; Koistinaho J; Banerjee P; Tanila H
J Neurochem; 2008 May; 105(3):584-94. PubMed ID: 18042177
[TBL] [Abstract][Full Text] [Related]
20. Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected].
Lamb BT; Sisodia SS; Lawler AM; Slunt HH; Kitt CA; Kearns WG; Pearson PL; Price DL; Gearhart JD
Nat Genet; 1993 Sep; 5(1):22-30. PubMed ID: 8220418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
